LRRK2 G2019S enhances immune response pathways and aggravates asthma in mouse models
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Kai Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Asthma, Disease Models, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Directorate for Geosciences, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Asthma is a complex inflammatory airway disease that arises from the interplay between genetic predisposition and environmental influences. Leucine-rich repeat kinase 2 (LRRK2), a gene commonly associated with Parkinson's disease, has recently gained attention for its role in immune regulation and inflammation beyond the brain. However, its involvement in asthma has not yet been reported. In this study, we used LRRK2 G2019S transgenic mice and LRRK2 knockout mice to establish asthmatic models to explore LRRK2 impact on asthma. We found that LRRK2 G2019S transgenic mice showed exacerbated airway hyperresponsiveness (AHR) and airway inflammation in asthma mouse models induced by house dust mite. RNA sequencing data unveiled that the LRRK2 G2019S mutation enhanced immune response pathways, including NOD-like receptor, cellular response to interferon β and activation of innate immune response signaling. Conversely, LRRK2 deficiency attenuated AHR and airway inflammation in the same asthma models. Our study offers new insights into the role of LRRK2 in allergic inflammation and highlights its potential as a therapeutic target for asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China; Institute of Respiratory Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electro…
- Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China. Electronic address: chen_xiqun@fudan.edu.cn.
Förderung
- Directorate for Geosciences
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Yang, K., Zhou, Y., Cui, J., Tang, W., Chen, Y., & Chen, X. (2024). LRRK2 G2019S enhances immune response pathways and aggravates asthma in mouse models. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150593
Vancouver
Yang K, Zhou Y, Cui J, Tang W, Chen Y, Chen X. LRRK2 G2019S enhances immune response pathways and aggravates asthma in mouse models. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150593
BibTeX
@article{Yang2024,
author = {Yang, Kai and Zhou, Yaolong and Cui, Jie and Tang, Weifeng and Chen, Yujun and Chen, Xiqun},
title = {LRRK2 G2019S enhances immune response pathways and aggravates asthma in mouse models},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150593}
}
EUVIMED